Cargando…

Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children

Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore, patients who have DHF should have a documented history of symptomatic dengue infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranawaka, Randula, Jayamanne, Chamara, Dayasiri, Kavinda, Samaranayake, Dinuka, Sandakelum, Udara, Hathagoda, Wathsala, Dissanayake, Ruwangi, Wickramasinghe, Pujitha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192182/
https://www.ncbi.nlm.nih.gov/pubmed/34122560
http://dx.doi.org/10.1155/2021/8842799
_version_ 1783706004994654208
author Ranawaka, Randula
Jayamanne, Chamara
Dayasiri, Kavinda
Samaranayake, Dinuka
Sandakelum, Udara
Hathagoda, Wathsala
Dissanayake, Ruwangi
Wickramasinghe, Pujitha
author_facet Ranawaka, Randula
Jayamanne, Chamara
Dayasiri, Kavinda
Samaranayake, Dinuka
Sandakelum, Udara
Hathagoda, Wathsala
Dissanayake, Ruwangi
Wickramasinghe, Pujitha
author_sort Ranawaka, Randula
collection PubMed
description Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore, patients who have DHF should have a documented history of symptomatic dengue infection in the past. A retrospective descriptive-analytical study was conducted at the University Paediatric Unit at Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. All children who had fulfilled the criteria for DHF admitted to the unit from April 2018 to September 2018 were recruited into the study. Relevant data were collected from bed head tickets. One hundred and eighty-four children were included in the final analysis. Thirty-three (17.9%) had a past history of documented symptomatic dengue infection, while 82.1% did not have a documented dengue infection. Twelve patients had dengue shock syndrome, and none of them had previously documented symptomatic dengue fever. Dextran was used in 96 patients in the critical phase. Twelve (42%) patients with past documented symptomatic dengue fever needed dextran while 84 (54.9%) patients without a documented past history of dengue fever needed dextran. In our clinical observation, we noticed that children with DHF mostly did not have a documented symptomatic prior dengue infection, while those with a documented symptomatic prior infection had a milder subsequent illness. In fact, the majority (82.1%) of patients with DHF did not have documented previous symptomatic dengue infection. It was also observed that the clinical course of subsequent dengue infection was less severe in patients with previously documented symptomatic dengue fever. This finding should be further evaluated in a larger scale study minimizing the all-confounding factors. This fact is more important in selecting recipients for vaccines against the dengue virus, which are supposed to produce immunity against the virus without causing the severe disease.
format Online
Article
Text
id pubmed-8192182
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81921822021-06-11 Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children Ranawaka, Randula Jayamanne, Chamara Dayasiri, Kavinda Samaranayake, Dinuka Sandakelum, Udara Hathagoda, Wathsala Dissanayake, Ruwangi Wickramasinghe, Pujitha J Trop Med Research Article Pathogenesis of dengue haemorrhagic fever is not fully understood, but it is thought that there is antibody enhancement during the secondary infection, which causes severe dengue haemorrhagic fever (DHF). Therefore, patients who have DHF should have a documented history of symptomatic dengue infection in the past. A retrospective descriptive-analytical study was conducted at the University Paediatric Unit at Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. All children who had fulfilled the criteria for DHF admitted to the unit from April 2018 to September 2018 were recruited into the study. Relevant data were collected from bed head tickets. One hundred and eighty-four children were included in the final analysis. Thirty-three (17.9%) had a past history of documented symptomatic dengue infection, while 82.1% did not have a documented dengue infection. Twelve patients had dengue shock syndrome, and none of them had previously documented symptomatic dengue fever. Dextran was used in 96 patients in the critical phase. Twelve (42%) patients with past documented symptomatic dengue fever needed dextran while 84 (54.9%) patients without a documented past history of dengue fever needed dextran. In our clinical observation, we noticed that children with DHF mostly did not have a documented symptomatic prior dengue infection, while those with a documented symptomatic prior infection had a milder subsequent illness. In fact, the majority (82.1%) of patients with DHF did not have documented previous symptomatic dengue infection. It was also observed that the clinical course of subsequent dengue infection was less severe in patients with previously documented symptomatic dengue fever. This finding should be further evaluated in a larger scale study minimizing the all-confounding factors. This fact is more important in selecting recipients for vaccines against the dengue virus, which are supposed to produce immunity against the virus without causing the severe disease. Hindawi 2021-06-02 /pmc/articles/PMC8192182/ /pubmed/34122560 http://dx.doi.org/10.1155/2021/8842799 Text en Copyright © 2021 Randula Ranawaka et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ranawaka, Randula
Jayamanne, Chamara
Dayasiri, Kavinda
Samaranayake, Dinuka
Sandakelum, Udara
Hathagoda, Wathsala
Dissanayake, Ruwangi
Wickramasinghe, Pujitha
Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children
title Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children
title_full Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children
title_fullStr Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children
title_full_unstemmed Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children
title_short Effect of Prior Symptomatic Dengue Infection on Dengue Haemorrhagic Fever (DHF) in Children
title_sort effect of prior symptomatic dengue infection on dengue haemorrhagic fever (dhf) in children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192182/
https://www.ncbi.nlm.nih.gov/pubmed/34122560
http://dx.doi.org/10.1155/2021/8842799
work_keys_str_mv AT ranawakarandula effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT jayamannechamara effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT dayasirikavinda effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT samaranayakedinuka effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT sandakelumudara effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT hathagodawathsala effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT dissanayakeruwangi effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren
AT wickramasinghepujitha effectofpriorsymptomaticdengueinfectionondenguehaemorrhagicfeverdhfinchildren